Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma
- PMID: 207782
- DOI: 10.1093/infdis/137.5.531
Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma
Abstract
Herpes zoster is a frequent complication of lymphoreticular malignancy. In this study two assays of in vitro cellular immune response to varicella-zoster virus (VZV) antigen, lymphocyte transformation and interferon production, were performed in normal subjects with recent and remote VZV infection. The responses of patients with lymphoma were measured before treatment and during long-term remission and then compared with those of normal subjects. Despite levels of antibody to VZV that were equivalent to those in normal subjects, 44% of the untreated lymphoma patients showed a lower transformation response to VZV antigen than the normal patients. Production of interferon in response to VZV antigen was absent in 32% of the untreated patients. In contrast, lymphocyte responses in untreated patients to herpes simplex virus antigen were within the range observed in a normal population. Interferon production by lymphocytes in response to cytomegalovirus antigen was also lower among untreated lymphoma patients than among normal patients, but lymphocyte transformation was not. Twenty-two percent of lymphoma patients in long-term remission continued to have diminished cellular immune responses to VZV antigen. Observations in these patient populations and in normal subjects with acute herpes zoster suggest that deficiencies in in vitro lymphocyte responses may correlate with increased susceptibility to clinical infection with VZV.
Similar articles
-
Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.Infect Immun. 1980 Aug;29(2):369-75. doi: 10.1128/iai.29.2.369-375.1980. Infect Immun. 1980. PMID: 6163709 Free PMC article.
-
Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.IARC Sci Publ (1971). 1978;(24 Pt 2):745-51. IARC Sci Publ (1971). 1978. PMID: 221398
-
Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.Clin Exp Immunol. 1983 Feb;51(2):197-206. Clin Exp Immunol. 1983. PMID: 6188564 Free PMC article.
-
Cellular and humoral immunity in Hodgkin's disease. I Patients in continuous long-term remission.Scand J Haematol. 1981 Sep;27(3):171-80. doi: 10.1111/j.1600-0609.1981.tb00469.x. Scand J Haematol. 1981. PMID: 6171864
-
[Ocular inflammation with varicella-zoster virus and immune privilege].Nippon Ganka Gakkai Zasshi. 2004 Nov;108(11):649-53. Nippon Ganka Gakkai Zasshi. 2004. PMID: 15584349 Review. Japanese.
Cited by
-
Insights into the pathogenesis of varicella viruses.Curr Clin Microbiol Rep. 2019 Sep;6(3):156-165. doi: 10.1007/s40588-019-00119-2. Epub 2019 Jul 6. Curr Clin Microbiol Rep. 2019. PMID: 32999816 Free PMC article.
-
Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.Infect Immun. 1980 Aug;29(2):369-75. doi: 10.1128/iai.29.2.369-375.1980. Infect Immun. 1980. PMID: 6163709 Free PMC article.
-
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.J Clin Invest. 1984 Oct;74(4):1204-13. doi: 10.1172/JCI111529. J Clin Invest. 1984. PMID: 6332826 Free PMC article.
-
Simian Varicella Virus: Molecular Virology and Mechanisms of Pathogenesis.Curr Top Microbiol Immunol. 2023;438:163-188. doi: 10.1007/82_2021_241. Curr Top Microbiol Immunol. 2023. PMID: 34669041 Free PMC article.
-
Pathogenesis and current approaches to control of varicella-zoster virus infections.Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Clin Microbiol Rev. 2013. PMID: 24092852 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources